Court Zaps Impax Suit Against Medicis Over Zit Drug

Law360 (April 17, 2008, 12:00 AM EDT) -- A California federal court has dismissed an Impax Laboratories Inc. case against Medicis Pharmaceutical Corp. for failing to show an immediate controversy regarding a patent for popular acne medication Solodyn.

U.S. District Judge Maxine M. Chesney of the Northern District of California granted Medicis' motion to dismiss the case on Wednesday. She found that Impax's abbreviated new drug application for a generic Solodyn and Medicis' statements that it would vigorously enforce the drug's underlying patent were not enough to keep the suit alive under the Declaratory...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.